Patient 006 (age 30, premenopausal, ECOG PS 0, MBC) was initially diagnosed with bilateral mammary carcinoma with large hepatic and lymph node metastases and bone metastases (stage IV, ER‐positive, PR‐positive, HER2 3+, Ki67 60%). The gene discussed is ERBB2; the disease is breast carcinoma.